Psychedelics such as psilocybin, ketamine, LSD and MDMA are lately being discussed because of their alleged potential to treat mental health disorders.
Biden plans to deliver his most extensive remarks yet about the aerial objects the military shot down
Biden will explain how the administration is forming rules to deal with other objects in the future.
Adani’s fall reignites scrutiny of billionaire’s close ties with Modi
The tycoon found the ground sinking beneath his feet and the fortunes of his businesses plummeting after a short-sellers report.
One dead, three injured after shooting inside El Paso mall
Cielo Vista Mall is next to the Walmart where 23 people were fatally shot four years ago.
This investor’s fund returned 15% in a bad year for stocks. He shares his playbook and bets for 2023
2022 was a bad year for the stock market. But a Singapore-based veteran investor’s fund knocked it out of the park. He tells CNBC Pro his best and worst trades.
Google asks employees to rewrite Bard’s bad responses, says the A.I. ‘learns best by example’
As Google races to get its artificial intelligence search tool up to speed, it wants employees to flag incorrect answers and even to rewrite them.
Cisco’s stellar quarter, guidance raise overshadowed by investor concerns about its backlog
Cisco Systems (CSCO) on Wednesday delivered a beat on revenue and profit for its fiscal second quarter, while significantly raising its guidance.
Asia markets mostly rise as U.S. sales jump; Japan posts worst trade deficit ever
Investors in the Asia-Pacific will digest the U.S. retail sales report that came in stronger than expected.
Dow closes 400 points lower as hot inflation report, comments from Fed’s Bullard raise rate hike fears: Live updates
“Both inflation readings this week point to the stickiness of inflation and that the fight isn’t over,” said one strategist.
Pro Picks: Watch all of Wednesday’s big stock calls on CNBC
A recap of Wednesday’s best stock picks on CNBC.